Sarcopenia prevalence in patients with cancer and association with adverse prognosis: A nationwide survey on common cancers

肌萎缩 医学 内科学 危险系数 癌症 人口 比例危险模型 风险因素 肿瘤科 置信区间 环境卫生
作者
Feng‐Min Zhang,Chunhua Song,Zengqing Guo,Zhen Yu,Min Weng,Fuxiang Zhou,Ming Liu,Minghua Cong,Tao Li,Zengning Li,Junqiang Chen,Jiuwei Cui,Hongxia Xu,Weidong Li,Hanping Shi,Cheng-Le Zhuang
出处
期刊:Nutrition [Elsevier BV]
卷期号:114: 112107-112107 被引量:17
标识
DOI:10.1016/j.nut.2023.112107
摘要

Although previous studies have implicated the negative outcomes of sarcopenia, evidence is limited to one or a few types of cancer. The aim of this study was to evaluate the distribution and influencing factors of sarcopenia, and explore the relationship between sarcopenia and cancer prognosis in a large oncological population.This observational cohort study included patients diagnosed with malignant cancer between May 2011 and January 2019. Hematologic and anthropometric parameters were collected prospectively. Low skeletal muscle mass and radiodensity were diagnosed using clinical indicators, according to the two prediction models. The importance of potential risk factors for sarcopenia was estimated by subtracting the predicted degrees of freedom from the partial χ2 statistic. Hazard rates of death were calculated using the hazard function and Cox regression analyses.We included 13 761 patients with cancer; the prevalence of sarcopenia was 33%. The median age was 58 y and 7135 patients (52%) were men. Patients with sarcopenia had a worse nutritional status and quality of life than those without sarcopenia. Age was the most important risk factor for sarcopenia compared with body mass index or TNM stage. Additionally, patients with sarcopenia had a significantly higher and earlier peak risk for mortality. After adjusting for baseline characteristics, sarcopenia was independently associated with mortality in the research population (hazard ratio, 1.429; P < 0.001) and most cancer types.Age is the most important risk factor for sarcopenia even in patients with cancer. Sarcopenia is strongly associated with a poor quality of life and reduced overall survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xyt完成签到 ,获得积分10
刚刚
慕白完成签到,获得积分20
刚刚
刚刚
爆米花的应助被科研通管家采纳,获得10
刚刚
科研通AI2S的应助被科研通管家采纳,获得10
1秒前
HenryCavill完成签到,获得积分10
1秒前
慕青的应助被科研通管家采纳,获得10
1秒前
情怀的应助被科研通管家采纳,获得10
1秒前
1秒前
小马甲的应助被科研通管家采纳,获得10
1秒前
海豚有海完成签到 ,获得积分10
1秒前
汉堡包的应助被科研通管家采纳,获得10
1秒前
大个的应助被科研通管家采纳,获得10
1秒前
1秒前
斯文败类的应助被科研通管家采纳,获得10
1秒前
1秒前
星辰大海的应助被科研通管家采纳,获得10
2秒前
SciGPT的应助被阿妤采纳,获得10
2秒前
2秒前
酷波er的应助被科研通管家采纳,获得10
2秒前
可爱的函函的应助被nmn采纳,获得10
3秒前
嘻嘻哈哈的应助被哈哈采纳,获得10
3秒前
Maestro_S的应助被钢铁Superman采纳,获得10
3秒前
科目三的应助被申晨曦采纳,获得10
3秒前
田様的应助被liang采纳,获得10
4秒前
orixero的应助被12581采纳,获得10
5秒前
田様的应助被怕黑的语芙采纳,获得10
5秒前
6秒前
zhuzhenghua发布了新的文献求助10
6秒前
在水一方的应助被孤独芷烟采纳,获得10
7秒前
科研通AI6.4的应助被XLYIDNNQJB采纳,获得10
7秒前
7秒前
8秒前
研友_VZG7GZ的应助被yiiy采纳,获得10
8秒前
田様的应助被王舒文采纳,获得10
8秒前
benjamin完成签到,获得积分10
9秒前
152455发布了新的文献求助10
10秒前
10秒前
lalaland发布了新的文献求助40
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170973
求助须知:如何正确求助?哪些是违规求助? 9563727
关于积分的说明 21771951
捐赠科研通 7762452
什么是DOI,文献DOI怎么找? 3430786
关于科研通互助平台的介绍 2554629
邀请新用户注册赠送积分活动 2475637